内科学（第三）講座

検索結果

• Supplementary Material for: Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma

  Hiraoka, A. (作成者), Kumada, T. (作成者), Tada, T. (作成者), Fukunishi, S. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Kawata, K. (作成者), Toyoda, H. (作成者), Ohama, H. (作成者), Tsutsui, A. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Arai, T. (作成者), Imai, M. (作成者), Nakamura, S. (作成者), Michitaka, K. (作成者), Hiasa, Y. (作成者) & Kudo, M. (作成者), Karger Publishers, 2020

  DOI: 10.6084/m9.figshare.11898228, https://karger.figshare.com/articles/Supplementary_Material_for_Nutritional_Index_as_Prognostic_Indicator_in_Patients_Receiving_Lenvatinib_Treatment_for_Unresectable_Hepatocellular_Carcinoma/11898228

  データセット

• Supplementary Material for: Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma

  Hiraoka, A. (作成者), Kumada, T. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Tada, T. (作成者), Toyoda, H. (作成者), Nouso, K. (作成者), Tsutsui, A. (作成者), Nagano, T. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Imai, M. (作成者), Joko, K. (作成者), Tanaka, H. (作成者), Tamai, T. (作成者), Koizumi, Y. (作成者), Hiasa, Y. (作成者), Michitaka, K. (作成者) & Kudo, M. (作成者), Karger Publishers, 2019

  DOI: 10.6084/m9.figshare.8869625, https://karger.figshare.com/articles/Supplementary_Material_for_Important_Clinical_Factors_in_Sequential_Therapy_Including_Lenvatinib_against_Unresectable_Hepatocellular_Carcinoma/8869625

  データセット

• Supplementary Material for: Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study

  Rossari, F. (寄稿者), Tada, T. (寄稿者), Suda, G. (寄稿者), Shimose, S. (寄稿者), Kudo, M. (寄稿者), Yoo, C. (寄稿者), Cheon, J. (寄稿者), Finkelmeier, F. (寄稿者), Lim, H. Y. (寄稿者), Masi, G. (寄稿者), Bergamo, F. (寄稿者), Amadeo, E. (寄稿者), Vitiello, F. (寄稿者), Kumada, T. (寄稿者), Iwamoto, H. (寄稿者), Aoki, T. (寄稿者), Chon, H. J. (寄稿者), Himmelsbach, V. (寄稿者), Iavarone, M. (寄稿者), Cabibbo, G. (寄稿者), Montes, M. (寄稿者), Foschi, F. G. (寄稿者), Vivaldi, C. (寄稿者), Soldà, C. (寄稿者), Sho, T. (寄稿者), Niizeki, T. (寄稿者), Nishida, N. (寄稿者), Steup, C. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Hiraoka, A. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Imai, M. (寄稿者), Kosaka, H. (寄稿者), Naganuma, A. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Kaibori, M. (寄稿者), Iijima, H. (寄稿者), Hiasa, Y. (寄稿者), Persano, M. (寄稿者), Foti, S. (寄稿者), Camera, S. (寄稿者), Stefanini, B. (寄稿者), Scartozzi, M. (寄稿者), Cascinu, S. (寄稿者), Casadei-Gardini, A. (寄稿者) & Rimini, M. (寄稿者), Karger Publishers, 2024

  DOI: 10.6084/m9.figshare.25573983.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Disease_etiology_impact_on_outcomes_of_hepatocellular_carcinoma_patients_treated_with_atezolizumab_plus_bevacizumab_a_real-world_multicenter_study/25573983/1

  データセット

• Supplementary Material for: Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma

  Hiraoka, A. (作成者), Kumada, T. (作成者), Tada, T. (作成者), Fukunishi, S. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Kawata, K. (作成者), Toyoda, H. (作成者), Ohama, H. (作成者), Tsutsui, A. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Arai, T. (作成者), Imai, M. (作成者), Nakamura, S. (作成者), Michitaka, K. (作成者), Hiasa, Y. (作成者) & Kudo, M. (作成者), Karger Publishers, 2020

  DOI: 10.6084/m9.figshare.11898228.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Nutritional_Index_as_Prognostic_Indicator_in_Patients_Receiving_Lenvatinib_Treatment_for_Unresectable_Hepatocellular_Carcinoma/11898228/1

  データセット

• Supplementary Material for: Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study

  Rossari, F. (寄稿者), Tada, T. (寄稿者), Suda, G. (寄稿者), Shimose, S. (寄稿者), Kudo, M. (寄稿者), Yoo, C. (寄稿者), Cheon, J. (寄稿者), Finkelmeier, F. (寄稿者), Lim, H. Y. (寄稿者), Masi, G. (寄稿者), Bergamo, F. (寄稿者), Amadeo, E. (寄稿者), Vitiello, F. (寄稿者), Kumada, T. (寄稿者), Iwamoto, H. (寄稿者), Aoki, T. (寄稿者), Chon, H. J. (寄稿者), Himmelsbach, V. (寄稿者), Iavarone, M. (寄稿者), Cabibbo, G. (寄稿者), Montes, M. (寄稿者), Foschi, F. G. (寄稿者), Vivaldi, C. (寄稿者), Soldà, C. (寄稿者), Sho, T. (寄稿者), Niizeki, T. (寄稿者), Nishida, N. (寄稿者), Steup, C. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Hiraoka, A. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Imai, M. (寄稿者), Kosaka, H. (寄稿者), Naganuma, A. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Kaibori, M. (寄稿者), Iijima, H. (寄稿者), Hiasa, Y. (寄稿者), Persano, M. (寄稿者), Foti, S. (寄稿者), Camera, S. (寄稿者), Stefanini, B. (寄稿者), Scartozzi, M. (寄稿者), Cascinu, S. (寄稿者), Casadei-Gardini, A. (寄稿者) & Rimini, M. (寄稿者), Karger Publishers, 2024

  DOI: 10.6084/m9.figshare.25573983, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Disease_etiology_impact_on_outcomes_of_hepatocellular_carcinoma_patients_treated_with_atezolizumab_plus_bevacizumab_a_real-world_multicenter_study/25573983

  データセット

• Supplementary Material for: Lenvatinib as second-line treatment after atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma –clinical results show importance of hepatic reserve function

  Hiraoka, A. (寄稿者), Kumada, T. (寄稿者), Tada, T. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Naganuma, A. (寄稿者), Kosaka, H. (寄稿者), Matono, T. (寄稿者), Kuroda, H. (寄稿者), Yata, Y. (寄稿者), Ohama, H. (寄稿者), Tada, F. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Yokohama, K. (寄稿者), Imai, M. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Iijima, H. (寄稿者), Kaibori, M. (寄稿者) & Hiasa, Y. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.23500869.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Lenvatinib_as_second-line_treatment_after_atezolizumab_plus_bevacizumab_for_unresectable_hepatocellular_carcinoma_clinical_results_show_importance_of_hepatic_reserve_function/23500869/1

  データセット

• Supplementary Material for: Relationship of atezolizumab plus bevacizumab treatment with muscle volume loss in unresectable hepatocellular carcinoma patients– multicenter analysis

  Hiraoka, A. (寄稿者), Kumada, T. (寄稿者), Tada, T. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Naganuma, A. (寄稿者), Kaibori, M. (寄稿者), Tanaka, T. (寄稿者), Ohama, H. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Joko, K. (寄稿者), Iijima, H. (寄稿者), Kosaka, H. (寄稿者), Hiasa, Y. (寄稿者) & Kudo, M. (寄稿者), Karger Publishers, 2022

  DOI: 10.6084/m9.figshare.21695111.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Relationship_of_atezolizumab_plus_bevacizumab_treatment_with_muscle_volume_loss_in_unresectable_hepatocellular_carcinoma_patients_multicenter_analysis/21695111/1

  データセット

• Supplementary Material for: Factors, including clinical trial eligibility, associated with induction of third-line treatment for advanced gastric cancer

  Ando, T. (寄稿者), Hosokawa, A. (寄稿者), Sakumura, M. (寄稿者), Motoo, I. (寄稿者), Kajiura, S. (寄稿者), Hirano, K. (寄稿者), Miwa, T. (寄稿者), Yokota, T. (寄稿者), Nakada, N. (寄稿者), Ueda, Y. (寄稿者), Ueda, A. (寄稿者), Tsukada, K. (寄稿者), Ogawa, K. (寄稿者), Nakaya, A. (寄稿者), Teramoto, A. (寄稿者), Nanjo, S. (寄稿者), Mihara, H. (寄稿者), Fujinami, H. (寄稿者), Fujii, T. (寄稿者) & Yasuda, I. (寄稿者), Karger Publishers, 2022

  DOI: 10.6084/m9.figshare.21101944, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Factors_including_clinical_trial_eligibility_associated_with_induction_of_third-line_treatment_for_advanced_gastric_cancer/21101944

  データセット

• Supplementary Material for: Relationship of atezolizumab plus bevacizumab treatment with muscle volume loss in unresectable hepatocellular carcinoma patients– multicenter analysis

  Hiraoka, A. (寄稿者), Kumada, T. (寄稿者), Tada, T. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Naganuma, A. (寄稿者), Kaibori, M. (寄稿者), Tanaka, T. (寄稿者), Ohama, H. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Joko, K. (寄稿者), Iijima, H. (寄稿者), Kosaka, H. (寄稿者), Hiasa, Y. (寄稿者) & Kudo, M. (寄稿者), Karger Publishers, 2022

  DOI: 10.6084/m9.figshare.21695111, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Relationship_of_atezolizumab_plus_bevacizumab_treatment_with_muscle_volume_loss_in_unresectable_hepatocellular_carcinoma_patients_multicenter_analysis/21695111

  データセット

• Supplementary Material for: Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab

  Persano, M. (寄稿者), Rimini, M. (寄稿者), Tada, T. (寄稿者), Suda, G. (寄稿者), Shimose, S. (寄稿者), Kudo, M. (寄稿者), Cheon, J. (寄稿者), Finkelmeier, F. (寄稿者), Lim, H. Y. (寄稿者), Masi, G. (寄稿者), Yoo, C. (寄稿者), Lonardi, S. (寄稿者), Stefanini, B. (寄稿者), Kumada, T. (寄稿者), Sakamoto, N. (寄稿者), Iwamoto, H. (寄稿者), Aoki, T. (寄稿者), Chon, H. J. (寄稿者), Himmelsbach, V. (寄稿者), Montes, M. (寄稿者), Vivaldi, C. (寄稿者), Soldà, C. (寄稿者), Hiraoka, A. (寄稿者), Sho, T. (寄稿者), Niizeki, T. (寄稿者), Nishida, N. (寄稿者), Steup, C. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Kosaka, H. (寄稿者), Naganuma, A. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Kaibori, M. (寄稿者), Iijima, H. (寄稿者), Hiasa, Y. (寄稿者), Burgio, V. (寄稿者), Ratti, F. (寄稿者), Aldrighetti, L. (寄稿者), Scartozzi, M. (寄稿者), Cascinu, S. (寄稿者) & Casadei-Gardini, A. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.21922089.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Role_of_the_prognostic_nutritional_index_in_predicting_survival_in_advanced_hepatocellular_carcinoma_treated_with_atezolizumab_plus_bevacizumab/21922089/1

  データセット

• Supplementary Material for: Lenvatinib as second-line treatment after atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma –clinical results show importance of hepatic reserve function

  Hiraoka, A. (寄稿者), Kumada, T. (寄稿者), Tada, T. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Naganuma, A. (寄稿者), Kosaka, H. (寄稿者), Matono, T. (寄稿者), Kuroda, H. (寄稿者), Yata, Y. (寄稿者), Ohama, H. (寄稿者), Tada, F. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Yokohama, K. (寄稿者), Imai, M. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Iijima, H. (寄稿者), Kaibori, M. (寄稿者) & Hiasa, Y. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.23500869, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Lenvatinib_as_second-line_treatment_after_atezolizumab_plus_bevacizumab_for_unresectable_hepatocellular_carcinoma_clinical_results_show_importance_of_hepatic_reserve_function/23500869

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138684, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138684

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138687, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138687

  データセット

• Supplementary Material for: What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

  Hiraoka, A. (作成者), Kumada, T. (作成者), Tada, T. (作成者), Kariyama, K. (作成者), Tani, J. (作成者), Fukunishi, S. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Kawata, K. (作成者), Yasuda, S. (作成者), Toyoda, H. (作成者), Ohama, H. (作成者), Nouso, K. (作成者), Tsutsui, A. (作成者), Nagano, T. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Arai, T. (作成者), Imai, M. (作成者), Koizumi, Y. (作成者), Nakamura, S. (作成者), Joko, K. (作成者), Michitaka, K. (作成者), Hiasa, Y. (作成者) & Kudo, M. (作成者), Karger Publishers, 2021

  DOI: 10.6084/m9.figshare.14113532, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_What_Can_Be_Done_to_Solve_the_Unmet_Clinical_Need_of_Hepatocellular_Carcinoma_Patients_following_Lenvatinib_Failure_/14113532

  データセット

• Supplementary Material for: Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab

  Persano, M. (寄稿者), Rimini, M. (寄稿者), Tada, T. (寄稿者), Suda, G. (寄稿者), Shimose, S. (寄稿者), Kudo, M. (寄稿者), Cheon, J. (寄稿者), Finkelmeier, F. (寄稿者), Lim, H. Y. (寄稿者), Masi, G. (寄稿者), Yoo, C. (寄稿者), Lonardi, S. (寄稿者), Stefanini, B. (寄稿者), Kumada, T. (寄稿者), Sakamoto, N. (寄稿者), Iwamoto, H. (寄稿者), Aoki, T. (寄稿者), Chon, H. J. (寄稿者), Himmelsbach, V. (寄稿者), Montes, M. (寄稿者), Vivaldi, C. (寄稿者), Soldà, C. (寄稿者), Hiraoka, A. (寄稿者), Sho, T. (寄稿者), Niizeki, T. (寄稿者), Nishida, N. (寄稿者), Steup, C. (寄稿者), Hirooka, M. (寄稿者), Kariyama, K. (寄稿者), Tani, J. (寄稿者), Atsukawa, M. (寄稿者), Takaguchi, K. (寄稿者), Itobayashi, E. (寄稿者), Fukunishi, S. (寄稿者), Tsuji, K. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Ogawa, C. (寄稿者), Nishimura, T. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Shimada, N. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Nouso, K. (寄稿者), Morishita, A. (寄稿者), Tsutsui, A. (寄稿者), Nagano, T. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Kosaka, H. (寄稿者), Naganuma, A. (寄稿者), Koizumi, Y. (寄稿者), Nakamura, S. (寄稿者), Kaibori, M. (寄稿者), Iijima, H. (寄稿者), Hiasa, Y. (寄稿者), Burgio, V. (寄稿者), Ratti, F. (寄稿者), Aldrighetti, L. (寄稿者), Scartozzi, M. (寄稿者), Cascinu, S. (寄稿者) & Casadei-Gardini, A. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.21922089, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Role_of_the_prognostic_nutritional_index_in_predicting_survival_in_advanced_hepatocellular_carcinoma_treated_with_atezolizumab_plus_bevacizumab/21922089

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138684.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138684/1

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138987, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138987

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138687.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138687/1

  データセット

• Supplementary Material for: Factors, including clinical trial eligibility, associated with induction of third-line treatment for advanced gastric cancer

  Ando, T. (寄稿者), Hosokawa, A. (寄稿者), Sakumura, M. (寄稿者), Motoo, I. (寄稿者), Kajiura, S. (寄稿者), Hirano, K. (寄稿者), Miwa, T. (寄稿者), Yokota, T. (寄稿者), Nakada, N. (寄稿者), Ueda, Y. (寄稿者), Ueda, A. (寄稿者), Tsukada, K. (寄稿者), Ogawa, K. (寄稿者), Nakaya, A. (寄稿者), Teramoto, A. (寄稿者), Nanjo, S. (寄稿者), Mihara, H. (寄稿者), Fujinami, H. (寄稿者), Fujii, T. (寄稿者) & Yasuda, I. (寄稿者), Karger Publishers, 2022

  DOI: 10.6084/m9.figshare.21101944.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Factors_including_clinical_trial_eligibility_associated_with_induction_of_third-line_treatment_for_advanced_gastric_cancer/21101944/1

  データセット

• Supplementary Material for: Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib

  Iavarone, M. (寄稿者), Alimenti, E. (寄稿者), Tada, T. (寄稿者), Shimose, S. (寄稿者), Suda, G. (寄稿者), Yoo, C. (寄稿者), Soldà, C. (寄稿者), Piscaglia, F. (寄稿者), Tosetti, G. (寄稿者), Marra, F. (寄稿者), Vivaldi, C. (寄稿者), Conti, F. (寄稿者), Schirripa, M. (寄稿者), Iwamoto, H. (寄稿者), Sho, T. (寄稿者), Lee, S. H. (寄稿者), Rizzato, M. D. (寄稿者), Tonnini, M. (寄稿者), Rimini, M. (寄稿者), Campani, C. (寄稿者), Masi, G. (寄稿者), Foschi, F. (寄稿者), Bruccoleri, M. (寄稿者), Kawaguchi, T. (寄稿者), Kumada, T. (寄稿者), Hiraoka, A. (寄稿者), Atsukawa, M. (寄稿者), Fukunishi, S. (寄稿者), Ishikawa, T. (寄稿者), Tajiri, K. (寄稿者), Ochi, H. (寄稿者), Yasuda, S. (寄稿者), Toyoda, H. (寄稿者), Hatanaka, T. (寄稿者), Kakizaki, S. (寄稿者), Kawata, K. (寄稿者), Tada, F. (寄稿者), Ohama, H. (寄稿者), Itokawa, N. (寄稿者), Okubo, T. (寄稿者), Arai, T. (寄稿者), Imai, M. (寄稿者), Naganuma, A. (寄稿者), Casadei-Gardini, A. (寄稿者) & Lampertico, P. (寄稿者), Karger Publishers, 2023

  DOI: 10.6084/m9.figshare.24138987.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Incidence_and_predictors_of_esophagogastric_varices_bleeding_in_patients_with_hepatocellular_carcinoma_in_lenvatinib/24138987/1

  データセット

• Supplementary Material for: Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma

  Hiraoka, A. (作成者), Kumada, T. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Kariyama, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Tada, T. (作成者), Toyoda, H. (作成者), Nouso, K. (作成者), Tsutsui, A. (作成者), Nagano, T. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Imai, M. (作成者), Joko, K. (作成者), Tanaka, H. (作成者), Tamai, T. (作成者), Koizumi, Y. (作成者), Hiasa, Y. (作成者), Michitaka, K. (作成者) & Kudo, M. (作成者), Karger Publishers, 2019

  DOI: 10.6084/m9.figshare.8869625.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Important_Clinical_Factors_in_Sequential_Therapy_Including_Lenvatinib_against_Unresectable_Hepatocellular_Carcinoma/8869625/1

  データセット

• Supplementary Material for: What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

  Hiraoka, A. (作成者), Kumada, T. (作成者), Tada, T. (作成者), Kariyama, K. (作成者), Tani, J. (作成者), Fukunishi, S. (作成者), Atsukawa, M. (作成者), Hirooka, M. (作成者), Tsuji, K. (作成者), Ishikawa, T. (作成者), Takaguchi, K. (作成者), Itobayashi, E. (作成者), Tajiri, K. (作成者), Shimada, N. (作成者), Shibata, H. (作成者), Ochi, H. (作成者), Kawata, K. (作成者), Yasuda, S. (作成者), Toyoda, H. (作成者), Ohama, H. (作成者), Nouso, K. (作成者), Tsutsui, A. (作成者), Nagano, T. (作成者), Itokawa, N. (作成者), Hayama, K. (作成者), Arai, T. (作成者), Imai, M. (作成者), Koizumi, Y. (作成者), Nakamura, S. (作成者), Joko, K. (作成者), Michitaka, K. (作成者), Hiasa, Y. (作成者) & Kudo, M. (作成者), Karger Publishers, 2021

  DOI: 10.6084/m9.figshare.14113532.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_What_Can_Be_Done_to_Solve_the_Unmet_Clinical_Need_of_Hepatocellular_Carcinoma_Patients_following_Lenvatinib_Failure_/14113532/1

  データセット